These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2046293)

  • 1. [Antiepileptic drugs in the combined medicinal prevention of motion sickness].
    Karkishchenko NN; Dimitriadi NA
    Kosm Biol Aviakosm Med; 1991; 25(1):21-3. PubMed ID: 2046293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nootropic agents in the complex treatment of patients with traumatic epilepsy].
    Lekomtsev VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(6):68-72. PubMed ID: 2171277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of oxiracetam and piracetam in combination with antiepileptic drugs.
    Mondadori C; Schmutz M
    Acta Neurol Scand Suppl; 1986; 109():113-6. PubMed ID: 3096070
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticonvulsant action of di-N-propylacetate combined with benzodiazepines, phenobarbital and phenytoin].
    Kosoĭ MIu
    Biull Eksp Biol Med; 1981 Apr; 91(4):458-60. PubMed ID: 6114759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-resistant epilepsy].
    Arroyo S; Rumiá J; Martínez I; Ribalta T
    Rev Neurol; 1998 Nov; 27(159):867-71. PubMed ID: 9859169
    [No Abstract]   [Full Text] [Related]  

  • 6. [New possibilities of pharmacotherapy in cardiovascular patients with mental disorders].
    Medvedev VE; Frolova VI; Epifanov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(9):30-7. PubMed ID: 25403298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin for motion sickness: clinical evaluation.
    Knox GW; Woodard D; Chelen W; Ferguson R; Johnson L
    Laryngoscope; 1994 Aug; 104(8 Pt 1):935-9. PubMed ID: 8052077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High anticonvulsant potency of gamma-aminobutyric acid (GABA)mimetic drugs in gerbils with genetically determined epilepsy.
    Löscher W; Frey HH; Reiche R; Schultz D
    J Pharmacol Exp Ther; 1983 Sep; 226(3):839-44. PubMed ID: 6411901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antiepileptic effects of complex therapy with vitamins and anticonvulsant preparations (experimental findings)].
    Kryzhanovskiĭ GN; Shandra AA; Nikushkin EV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(6):84-90. PubMed ID: 6214131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aminalon as an agent for the prevention of motion sickness].
    Lapaev EV; Voinova II; Vorob'ev OA; Barmicheva NM
    Zh Ushn Nos Gorl Bolezn; 1978; (5):35-9. PubMed ID: 360685
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychophysiological effects of combined administration of pantogam and potassium orotate in patients with neurotic disorders].
    Ben'kovich BI; Gorshkova IA; Gershanovich II; Faĭzulloev AZ
    Eksp Klin Farmakol; 2001; 64(3):26-8. PubMed ID: 11558433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Requirement of an "ideal" drug for prevention of space motion sickness].
    Karkishchenko NN
    Kosm Biol Aviakosm Med; 1989; 23(6):33-6. PubMed ID: 2516579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative investigation of calcium ketopantoylaminobutyrate and pantogam: tranquilizer activity].
    Karaev AL; Kozlova GS; Smirnova TN; Gunar VI
    Eksp Klin Farmakol; 2004; 67(6):20-2. PubMed ID: 15707008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of pantogam, nicotinamide, and phenazepam on seizure activity].
    Kryzhanovskiĭ GN; Shandra AA; Godlevskiĭ LS; Nikushkin EV
    Biull Eksp Biol Med; 1982 Sep; 94(9):61-4. PubMed ID: 6216928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pantogam in daily psychiatric practice].
    Kontsevoĭ VA; Rotshteĭn VG; Bogdan MN; Riakhovskiĭ VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):34-9. PubMed ID: 18427457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazepam as an anti-motion sickness drug.
    McClure JA; Lycett P; Baskerville JC
    J Otolaryngol; 1982 Aug; 11(4):253-9. PubMed ID: 7131636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of metabolically active preparations to study mild forms of mental deficiency].
    Ermolina LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(3):439-43. PubMed ID: 7395427
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation of the anticonvulsant effects of antiepileptic drugs by "nootropics"; a potential new therapeutic approach.
    Mondadori C; Schmutz M; Baltzer V
    Acta Neurol Scand Suppl; 1984; 99():131-2. PubMed ID: 6430020
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pantogam active in the complex treatment of dystonic hyperkineses].
    Katunina EA; Malykhina EA; Avanesova OV; Makarova AA; Abdurakhmanova EK; Gridiakin VI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):57-61. PubMed ID: 21389940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations.
    Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H
    Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.